Abstract
Pain still ranks among the highest patient as well as surgeon concerns for unwanted surgical outcomes. Thus, pain management plays a major role in patient satisfaction and improving our patients’ safety. This chapter will review the pathogenesis of pain. Strategies for pain control will be addressed. Additionally, various pain disorders which can affect our patients’ postoperative course will be discussed.
This is a preview of subscription content, log in via an institution.
References
Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA. 2000;284:428–9.
Rawal N, Hylander J, Nydahl PA, Olofsson I, Gupta A. Survey of postoperative analgesia following ambulatory surgery. Acta Anaesthesiol Scand. 1997;41:1017–22.
Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–40.
Rathmell JP, Wu CL, Sinatra RS, et al. Acute post-surgical pain management: a critical appraisal of current practice, December 2–4, 2005. Reg Anesth Pain Med. 2006;31(4 Suppl 1):1–42.
Seymour RA, Walton JG. Pain control after third molar surgery. Int J Oral Surg. 1984;13:457–85.
Szmyd L, Shannon IL, Mohnac AM. Control of postoperative sequelae in impacted third molar surgery. J Oral Ther Pharmacol. 1965;1:491–6.
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–25.
Woolf CJ, Ma Q. Nociceptors-noxious stimulus detectors. Neuron. 2007;55:353–64.
Jahr CE, Jessell TM. ATP excites a subpopulation of rat dorsal horn neurones. Nature. 1983;304:730–3.
Coffman J. The effect of aspirin in pain and hand blood flow responses to intra-arterial injection of bradykinin. Clin Pharmacol Ther. 1966;7:26–37.
Douglas WW. Histamine and 5-hydroxytryptamine and their anatgonist. In: Gilman AG, Goodman LS, editors. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan; 1985. p. 605–38.
Moncada S, Flower RJ, Vane JR. Prostaglandins, prostacyclin, thromboxane A2, and leukotrienes. In: Gilman AG, Goodman LS, editors. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan; 1985. p. 660–73.
Higgs GA, Salmon JA, Henderson B. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity. Proc Natl Acad Sci U S A. 1987;84:1417–20.
Higgs GA. Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics. Br J Pharmacol. 1980;10(Suppl 2):233–5.
Ferreira SH, Nakamura M, AbreuCatro MS. The hyperalgesic effects of prostacyclin and PGE2. Prostaglandins. 1978;16:31–7.
Woo YC, Park SS, Subieta AR, et al. Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain. Anesthesiology. 2004;101:468–75.
Kim TJ, Freml L, Park SS, et al. Lactate concentrations in incisions indicate ischemic-like conditions may contribute to postoperative pain. J Pain. 2007;8:59–66.
Immke DC, McCleskey EW. Lactate enhances the acid-sensing Na channel on ischemia-sensing neurons. Nat Neurosci. 2001;4:869–70.
D’Mello R, Dickenson AH. Spinal cord mechanisms of pain. Br J Anaesth. 2008;101:8–16.
Campbell JN, Raja SN, Meyer RA. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain. 1988;32:89–94.
McCartney CJL, Sinha A, Katz J. A qualitative systematic review of the role of N-Methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg. 2004;98:1385–400.
Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19.
Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–64.
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–8.
Sandkuhler J. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev Suppl. 2009;89:707–58.
Pogatzki-Zahn EM, Zahn PK. From preemptive to preventive analgesia. Curr Opin Anaesthesiol. 2006;19:551–5.
White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005;101(5 Suppl):S5–22.
Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manag. 2003;25:276–83.
Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62:4491–8.
Singleton PA, Moss J. Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010;6:1237–42.
Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology. 2005;102:1249–60.
Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005;103:1296–304.
Moiniche S, Romsing J, Dahl JB, Tramer MR. Nonsteroidal anti-inflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg. 2003;96:68–77, table of contents.
Marret E, Flahault A, Samama CM, Bonnet F. Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology. 2003;98:1497–502.
Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand. 2004;48:525–46.
White PF, Kehlet H, Liu S. Perioperative analgesia: what do we still know? Anesth Analg. 2009;108:1364–7.
Nussmeier NA, Whelton AA, Brown MT, et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology. 2006;104:518–26.
Menigaux C, Guignard B, Fletcher D, Sessler DI, Dupont X, Chauvin M. Intraoperative small-dose ketamine enhances analgesia after outpatient knee arthroscopy. Anesth Analg. 2001;93:606–12.
Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004;99:482–95, table of contents.
Chandrakantan A, Glass PSA. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011;107(S1):i27–40.
Hossmann V, Maling TJ, Hamilton CA, et al. Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther. 1980;28:167–76.
Lin TF, Yeh YC, Lin FS, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth. 2009;102:117–22.
Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98:153–8, table of contents.
Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106:1741–8.
Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg. 1996;82:44–51.
Bisgaard T, Klarskov B, Kristiansen VB, et al. Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. Anesth Analg. 1999;89:1017–24.
Klein SM, Nielsen KC, Greengrass RA, Warner DS, Martin A, Steele SM. Ambulatory discharge after long-acting peripheral nerve blockade: 2382 blocks with ropivacaine. Anesth Analg. 2002;94:65–70, table of contents.
Vogel JD. Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial. J Pain Res. 2013;6:605–10.
US Food and Drug Administration. FDA Label Approved on 10/28/2011 (PDF) for EXPAREL. US Silver Spring, MD: US Food and Drug Administration. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022496Orig1s000TOC.cfm. Accessed 7 Mar 2014.
Chahar P, Cummings KC III. Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res. 2012;5:257–64.
Chan MT, Wan AC, Gin T, Leslie K, Myles PS. Chronic postsurgical pain after nitrous oxide anesthesia. Pain. 2011;152:2514–20.
Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain. 2003;7:181–8.
Fountas KN, Kapsalaki EZ, Johnston KW, Smisson HF III, Vogel RL, Robinson JS Jr. Postoperative lumbar microdiscectomy pain. Minimalization by irrigation and cooling. Spine (Phila Pa 1976). 1999;24:1958–60.
Politis C, Lambrichts I, Agbaje JO. Neuropathic pain after orthognathic surgery. Oral Maxillofac Surg. 2014;117(2):102–7.
Hillerup S. Iatrogenic injury to the inferior alveolar nerve: etiology, signs and symptoms, and observations on recovery. Int J Oral Maxillofac Surg. 2008;37(8):704–9.
Renton T, Thexton A, Crean SJ, Hankins M. Simplifying the assessment of the recovery from surgical injury to the lingual nerve. Br Dent J. 2006;200(10):569–73.
Lam NP, Donoff RB, Kaban LB, Dodson TB. Patient satisfaction after trigeminal nerve repair. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(5):538–43.
Ziccardi VB, Zuniga JR. Nerve injuries after third molar removal. Oral Maxillofac Surg Clin North Am. 2007;19(1):105–15.
Pogrel MA. The results of microneurosurgery of the inferior alveolar and lingual nerve. J Oral Maxillofac Surg. 2002;60(5):485–9.
Susarla SM, Kaban LB, Donoff RB, et al. Functional sensory recovery after trigeminal nerve repair. J Oral Maxillofac Surg. 2007;65(1):60–5.
Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005451.
Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD001133.
Sato J, Saitoh T, Notani K, et al. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):18–22.
Taylor JC, Brauer S, Espir ML. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J. 1981;57(663):16–8.
Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain. 2002;95(3):259–66.
Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15(3):240–4.
Cheshire WP Jr. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain. 2002;3(2):137–42.
Beniczky S, Tajti J, Timea Varga E, et al. Evidence-based pharmacological treatment of neuropathic pain syndromes. J Neural Transm. 2005;112(6):735–49.
Saarto T, Wiffen PJ. Antidepressants for treating neuropathic pain. Cochrane Evid. 2007:CD005454.
Collins S, Sigtermans MJ, Dahan A, Zuurmond WW, Perez RS. NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med. 2010;11:1726–42.
Bonelli S, Conoscente F, Movilia PG, Restelli L, Francucci B, Grossi E. Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial. Pain. 1983;16:297–307.
Peters G, Nurmikko TJ. Peripheral and gasserian ganglion-level procedures for the treatment of trigeminal neuralgia. Clin J Pain. 2002;18(1):28–34.
Quinn JH, Weil T. Trigeminal neuralgia: treatment by repetitive peripheral neurectomy. Supplemental report. J Oral Surg. 1975;33(8):591–5.
Pradel W, Hlawitschka M, Eckelt U, et al. Cryosurgical treatment of genuine trigeminal neuralgia. Br J Oral Maxillofac Surg. 2002;40(3):244–7.
Fardy MJ, Zakrzewska JM, Patton DW. Peripheral surgical techniques for the management of trigeminal neuralgia alcohol and glycerol injections. Acta Neurochir. 1994;129(3–4):181–4.
Erdem E, Alkan A. Peripheral glycerol injections in the treatment of idiopathic trigeminal neuralgia: retrospective analysis of 157 cases. J Oral Maxillofac Surg. 2001;59(10):1176–80.
Taha JM, Tew JM Jr. Comparison of surgical treatments for trigeminal neuralgia: reevaluation of radiofrequency rhizotomy. Neurosurgery. 1996;38(5):865–71.
Hampf G, Vikkula J, Ylipaavalniemi P, Aalberg V. Psychiatric disorders in orofacial dysaesthesia. Int J Oral Maxillofac Surg. 1987;16:402–7.
Vickers ER, Boocock H, Harris RD, et al. Analysis of the acute postoperative pain experience following oral surgery: identification of ‘unaffected’, ‘disabled’ and ‘depressed, anxious and disabled’ patient clusters. Aust Dent J. 2006;51:69–77.
Varamini P, Goh WH, Mansfeld FM, et al. Peripherally acting novel lipoendomorphin-1 peptides in neuropathic pain without producing constipation. Bioorg Med Chem. 2013;21:1898–904.
Carlsson-Jonsson A, Gao T, Hao JX, et al. N-terminal truncations of substance P 1-7 amide affect its action on spinal cord injury-induced mechanical allodynia in rats. Eur J Pharmacol. 2014;738:319–25.
Serhan CN, Dalli J, Karamnov S, et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 2012;26:1755–65.
Ellis JA, Mejia Munne JC, Winfree CJ. Trigeminal branch stimulation for the treatment of intractable craniofacial pain. J Neurosurg. 2015;123:283–8.
Vickers ER, Karsten E, Flood J, Lilischkis R. A preliminary report on stem cell therapy for neuropathic pain in humans. J Pain Res. 2014;7:255–63.
Katusic S, Williams DB, Beard CM, et al. Incidence and clinical features of glossopharyngeal neuralgia, Rochester, Minnesota, 1945–1984. Neuroepidemiology. 1991;10(5–6):266–75.
Olesen J, Bousser M-G, Diener HC, et al. The international classification of headache disorders. 2nd edition. Cephalalgia. 2004;24(Suppl 1):24–150.
Renton T. Persistent pain after dental surgery. Rev Pain. 2011;5(1):8–17.
Evans RW, Agostoni E. Persistent idiopathic facial pain. Headache. 2006;46(8):1298–300.
Pfaffenrath V, Rath M, Pollmann W, et al. Atypical facial pain–application of the IHS criteria in a clinical sample. Cephalalgia. 1993;13(Suppl 12):84–8.
Baad-Hansen L. Atypical odontalgia—pathophysiology and clinical management. J Oral Rehabil. 2008;35(1):1–11.
Birklein F. Complex regional pain syndrome. J Neurol. 2005;252(2):131–8.
Wasner G, Schattschneider J, Baron R. Skin temperature side differences da diagnostic tool for CRPS? Pain. 2002;98(1–2):19–26.
Benoliel R, Eliav E. Neuropathic orofacial pain. Oral Maxillofacial Surg Clin North Am. 2008;20:237–54.
Melis M, Zawawi K, al-Badawi E, et al. Complex regional pain syndrome in the head and neck: a review of the literature. J Orofac Pain. 2002;16(2):93–104.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Rizk, M.S., Bahjah, S.S., Ayoub, C.M. (2018). Improving Pain Management in Maxillofacial Cosmetic Surgical Procedures. In: Ferneini, E., Castiglione, C., Banki, M. (eds) Complications in Maxillofacial Cosmetic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-58756-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-58756-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58755-4
Online ISBN: 978-3-319-58756-1
eBook Packages: MedicineMedicine (R0)